Tag: delcath systems
Delcath Systems receives US FDA authorisation for Hepzato phase two clinical...
Delcath Systems has announced that the US Food and Drug Administration (FDA) has completed its 30-day review of the company's investigational new drug (IND)...
Delcath Systems announces publication of study comparing chemosaturation and SIRT
Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, have announced the publication of an...
Delcath Systems announces new drug application resubmission for Hepzato Kit
Delcath Systems has announced it has submitted a new drug application (NDA) resubmission to the US Food and Drug Administration (FDA) for the Hepzato...
Delcath Systems announces updated results from CHOPIN phase 1b trial
Delcath Systems has shared in a press release the publication of updated results from the phase 1b CHOPIN Trial, conducted at Leiden University Medical...
